SC Filed 2022-01-12 Event — SEC 0001193125-22-007708 →

Clarus Lifesciences III, L.P. → ESSA Pharma Inc.

Stake: — Shares: —

Composite Decision Signal · PASS (LOW BASE-RATE EDGE) Conviction Score: 6/100

Passive Schedule 13G filer baseline

Item 4 — Purpose of Transaction

Not extracted from this filing — typically because it's an amendment (13D/A) and Item 4 is unchanged from the parent filing. Read the raw SEC filing →

Cross-References

Insider Activity (last 365d)

0 transactions

0 buys · 0 sales · 0 awards/exercises

Issuer Cluster

4 13D/G filings on this issuer

3 other filings besides this one

Filer Track Record

10 filings by this filer

9 other filings in the data moat

Short Interest

—

Not in latest FINRA snapshot

Other 13D/G Filings on ESSA Pharma Inc.

Filed	Form	Filer	Stake	Shares
2025-07-21	SCHEDULE	Soleus Capital Master Fund, L.P.	9.80%	4,362,026	view →
2019-07-15	SC	EVENTIDE ASSET MANAGEMENT, LLC	—	—	view →
2019-01-11	SC	Clarus Lifesciences III, L.P.	—	—	view →

Other Filings by Clarus Lifesciences III, L.P.

Filed	Form	Issuer	Stake	Shares
2023-01-12	SC	Imago BioSciences, Inc.	—	—	view →
2022-04-01	SC	Imago BioSciences, Inc.	—	—	view →
2020-07-09	SC	Entasis Therapeutics Holdings Inc.	—	—	view →
2019-08-06	SC	AVROBIO, Inc. TECX	—	—	view →
2019-01-11	SC	Entasis Therapeutics Holdings Inc.	—	—	view →
2019-01-11	SC	AVROBIO, Inc. TECX	—	—	view →
2019-01-11	SC	ESSA Pharma Inc.	—	—	view →
2019-01-11	SC	Forty Seven, Inc.	—	—	view →
2019-01-11	SC	Gritstone Oncology, Inc.	—	—	view →

Want this depth on every filing the moment it hits SEC EDGAR?

Free $0 (48h-delayed alerts) · Individual $49/mo (real-time) · Team & API $199/mo · Enterprise.

See pricing →